HIF1A and neoplasm: 2010), and diminishes tumor growth (Kwon et al. 2010), angiogenesis, and vascularization by inhibiting the levels of proangiogenesis factors, Cox-2, and HIF-1α in tumor tissues (Kwon et al. 2009).